Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Profit after tax (before exceptional items) up 23% to Rs 215 crores
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush
Increased capability to produce medicines for challenging diseases including cancer
The World Homoeopathy Day commemorates the birth anniversary of Dr Samuel Hahnemann on 10th of April
Subscribe To Our Newsletter & Stay Updated